Inhibition and reversal of platelet-rich arterial thrombus in vivo: direct vs. indirect factor Xa inhibition

J Thromb Haemost. 2004 Dec;2(12):2162-9. doi: 10.1111/j.1538-7836.2004.01040.x.

Abstract

Background/objective: The efficacy of a direct factor (F)Xa inhibitor, ZK-807834, was compared with indirect inhibition by enoxaparin for inhibition and deaggregation of acute platelet-rich thrombi in a well-characterized porcine carotid injury model.

Methods: A crush injury was performed on a randomly chosen carotid artery and the thrombus allowed to propagate for 30 min. Pigs then received intravenous drug for 35 min: ZK-807834-Dose 1 (40 microg kg(-1) bolus + 1.5 microg kg(-1) min(-1) infusion, n=6); ZK-807834-Dose 2 (20 microg kg(-1) bolus + 0.75 microg kg(-1) min(-1) infusion; n=6); enoxaparin (1 mg kg(-1) bolus; n=6); or saline (n=6). Five minutes after drug initiation, the contralateral artery was injured. Thrombus size was monitored by scintillation detection of autologous 111In-platelets.

Results: The prothrombin time ratio was 2.2 +/- 0.1; 1.4 +/- 0.3; 1.2 +/- 0.9 and 1.1 +/- 0.2, respectively. ZK-807834-Dose 1 significantly inhibited carotid platelet deposition (525 +/- 226 x 10(6) cm(-2); P = 0.008), whereas ZK-807834-Dose 2 (2325 +/- 768) and enoxaparin (1236 +/- 383) were not different from saline (2776 +/- 642). Thrombus deaggregation was greatest for animals receiving ZK-807834-Dose 1 (473 +/- 185). Neither ZK-807834-Dose 2 (1588 +/- 480) nor enoxaparin (1618 +/- 686) was different from saline control (2222 +/- 598).

Conclusions: Direct FXa inhibition with ZK-807834, at a prothrombin time ratio of 2.2, effectively inhibits thrombosis and promptly deaggregates thrombi induced by arterial injury. In contrast, indirect FXa inhibition with enoxaparin was ineffective.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amidines / pharmacology
  • Animals
  • Anticoagulants / pharmacology
  • Blood Platelets / metabolism*
  • Carotid Arteries / pathology*
  • Carotid Artery Thrombosis / drug therapy*
  • Carotid Artery Thrombosis / prevention & control*
  • Dose-Response Relationship, Drug
  • Enoxaparin / pharmacology
  • Factor Xa Inhibitors
  • Female
  • Heparin / metabolism
  • Inhibitory Concentration 50
  • Perfusion
  • Prothrombin Time
  • Pyridines / pharmacology
  • Swine
  • Thrombosis / drug therapy
  • Thrombosis / prevention & control
  • Time Factors

Substances

  • Amidines
  • Anticoagulants
  • Enoxaparin
  • Factor Xa Inhibitors
  • Pyridines
  • Fidexaban
  • Heparin